Condition: Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other clinical efficacy and safety outcomes in the target subject population.

Location(s): Lake City

Condition: Chronic Obstructive Pulmonary Disease (COPD)